Product NDC: | 16590-911 |
Proprietary Name: | BUTALBITAL, ASPIRIN, AND CAFFEINE |
Non Proprietary Name: | BUTALBITAL, ASPIRIN, AND CAFFEINE |
Active Ingredient(s): | 325; 50; 40 mg/1; mg/1; mg/1 & nbsp; BUTALBITAL, ASPIRIN, AND CAFFEINE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-911 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017534 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19760504 |
Package NDC: | 16590-911-72 |
Package Description: | 120 CAPSULE in 1 BOTTLE (16590-911-72) |
NDC Code | 16590-911-72 |
Proprietary Name | BUTALBITAL, ASPIRIN, AND CAFFEINE |
Package Description | 120 CAPSULE in 1 BOTTLE (16590-911-72) |
Product NDC | 16590-911 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BUTALBITAL, ASPIRIN, AND CAFFEINE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19760504 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | STAT RX USA LLC |
Substance Name | ASPIRIN; BUTALBITAL; CAFFEINE |
Strength Number | 325; 50; 40 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |